- Home
- DVLT vs ONCY Comparison
DVLT vs ONCY Comparison
Compare DVLT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVLT
- ONCY
- Stock Information
- Founded
- DVLT 2010
- ONCY 1998
- Country
- DVLT United States
- ONCY Canada
- Employees
- DVLT N/A
- ONCY N/A
- Industry
- DVLT
- ONCY Pharmaceuticals and Biotechnology
- Sector
- DVLT
- ONCY Health Care
- Exchange
- DVLT NYSE
- ONCY Nasdaq
- Market Cap
- DVLT 55.7M
- ONCY 49.1M
- IPO Year
- DVLT N/A
- ONCY 1999
- Fundamental
- Price
- DVLT $0.72
- ONCY $0.69
- Analyst Decision
- DVLT Strong Buy
- ONCY Strong Buy
- Analyst Count
- DVLT 1
- ONCY 4
- Target Price
- DVLT $3.00
- ONCY $4.33
- AVG Volume (30 Days)
- DVLT 445.5K
- ONCY 1.4M
- Earning Date
- DVLT 08-13-2025
- ONCY 07-31-2025
- Dividend Yield
- DVLT N/A
- ONCY N/A
- EPS Growth
- DVLT N/A
- ONCY N/A
- EPS
- DVLT N/A
- ONCY N/A
- Revenue
- DVLT $3,048,000.00
- ONCY N/A
- Revenue This Year
- DVLT $434.03
- ONCY N/A
- Revenue Next Year
- DVLT $221.43
- ONCY N/A
- P/E Ratio
- DVLT N/A
- ONCY N/A
- Revenue Growth
- DVLT 63.08
- ONCY N/A
- 52 Week Low
- DVLT $0.60
- ONCY $0.33
- 52 Week High
- DVLT $3.34
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- DVLT N/A
- ONCY 69.96
- Support Level
- DVLT N/A
- ONCY $0.56
- Resistance Level
- DVLT N/A
- ONCY $0.37
- Average True Range (ATR)
- DVLT 0.00
- ONCY 0.07
- MACD
- DVLT 0.00
- ONCY 0.04
- Stochastic Oscillator
- DVLT 0.00
- ONCY 83.26
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.